From: Effects of currently prescribed LDL-C-lowering drugs on PCSK9 and implications for the next generation of LDL-C-lowering agents
Atorvastatin Dose (mg/day)
Duration of treatment (weeks)
Increase in serum PCSK9 levels (%)
Author and study (reference)
10
6
14
Costet et al. [52]
40
12
34
Careskey et al. [48]
80
16
47
Welder et al. [51]